文献速递甲状腺疾病性腺与生殖内分泌

母体甲状腺激素失衡与子代孤独症谱系障碍风险

Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

但慢性合并妊娠期甲减及甲减持续时间越长与ASD风险升高相关。

要点

  • 仅慢性甲减(可能已充分治疗)与子代ASD风险无显著关联。
  • 慢性合并妊娠期甲减者子代ASD风险升高(aHR 2.61)。
  • 甲减暴露孕期越长,子代ASD风险越高,呈剂量-反应趋势。

核心结论

  • 充分治疗的慢性甲减与子代ASD无显著关联,而贯穿多个孕期的持续甲状腺激素失衡与ASD风险升高相关。
  • 研究提示孕期应常规筛查甲状腺功能并及时治疗。

研究设计与样本

  • 回顾性队列研究,随访至2021年1月,单家三级医院(以色列南部Soroka大学医学中心),并与Clalit健康服务电子病历链接。
  • 主要结局为子代ASD诊断(依据DSM-5)。

主要发现

  • 仅慢性甲减与ASD无显著关联(aHR 0.47;95%CI 0.15-1.48)。
  • 慢性合并妊娠期甲减与ASD风险升高相关(aHR 2.61;95%CI 1.44-4.74)。
  • 甲减暴露1、2、3个孕期者aHR分别为1.69(95%CI 1.19-2.83)、2.39(95%CI 1.24-5.78)、3.25(95%CI 1.07-7.21)。

关键数值与推荐

  • 甲状腺功能异常定义为母亲甲状腺功能异常,共4409例(8.6%)。
  • ASD诊断依据DSM-5标准。
  • 甲减暴露孕期数与ASD风险呈剂量-反应关系(1、2、3个孕期aHR依次为1.69、2.39、3.25)。

临床怎么用

  • 孕期应常规筛查甲状腺功能,并对甲减及时治疗。
  • 对持续多个孕期甲状腺激素失衡者,应关注子代神经发育并加强随访。

局限性

  • 单中心回顾性队列,结果外推需谨慎。
  • 仅慢性甲减组样本量有限,部分估计置信区间较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Maternal thyroid hormones are essential for fetal neurodevelopment. Gestational thyroid imbalance has been associated with atypical neurodevelopment, including increased risk of autism spectrum disorder (ASD). OBJECTIVE: To examine the association between maternal thyroid dysfunction and ASD risk in offspring. DESIGN: Retrospective cohort study with follow-up through January 2021. SETTING: Single tertiary hospital in southern Israel (Soroka University Medical Center); linked to Clalit Health Services electronic records. PATIENTS OR OTHER PARTICIPANTS: A total of 51 296 singleton births between January 2011 and December 2017. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Offspring ASD diagnosis (Diagnostic and Statistical Manual of Mental Disorders, fifth edition). RESULTS: A total of 4409 (8.6%) of the mothers showed abnormal thyroid function. ASD cumulative incidence was similar in the offspring of women with normal and abnormal thyroid function (log-rank P = .27). While chronic hypothyroidism only (reflecting likely adequate treatment) was not significantly associated with ASD [adjusted hazard ratio (aHR), 0.47; 95% confidence interval (CI), 0.15-1.48], combined chronic and gestational hypothyroidism was associated with higher ASD risk (aHR, 2.61; 95% CI, 1.44-4.74). Trimester-specific analysis indicated a dose-response effect, in which the longer the period of hypothyroidism, the higher the ASD risk, namely, for 1, 2, or 3 trimesters of exposure: aHR, 1.69 (95% CI, 1.19-2.83); aHR, 2.39 (95% CI, 1.24-5.78); aHR, 3.25 (95% CI, 1.07-7.21), respectively. CONCLUSION: The findings suggest adequately treated chronic hypothyroidism is not associated with ASD in offspring, whereas persistent hormonal imbalance across trimesters conveys elevated risk. These findings underscore the importance of routine thyroid function screening and timely treatment throughout pregnancy.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Elbedour L, Weinberg M, Meiri G, et al. Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder. J Clin Endocrinol Metab. 2026. PMID: 41288361. doi:10.1210/clinem/dgaf596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。